The EB1/RP1 family is a new protein family that is characterized by the ability of its members to serve as interacting partners for the adenomatous polyposis coli (APC) tumour suppressor protein and tubulin. Data obtained with highly conserved yeast homologues suggest that the EB1/RP1 protein family promotes cytoplasmic microtubule dynamics and contributes to the sensor mechanism controlling the cytokinesis checkpoint during mitosis. However, the precise function of this protein family in mammalian cells has not been elucidated so far and remains unclear. Here, we report on the genomic localization of the RP1 gene and the characterization of the corresponding promoter. The RP1 gene was found to be encoded on chromosome 18q21, a locus which is altered or deleted in up to 50% of all patients with colorectal cancer. Promoter analysis revealed that the RP1 gene is under the control of a strong promoter that was 10 times more active in mammalian cells when compared to SV40 promoter. Members of the cyclic AMP response element binding protein family (CREB1 and CREB2) could be identi®ed as transcription factors binding speci®cally within the RP1 promoter sequence. Oncogene (2001) 20, 5920 ± 5929.
Introduction
The adenomatous polyposis coli (APC) tumoursuppressor protein controls the wnt-signalling pathway by forming a complex with glycogen synthase kinase 3b (GSK-3b), axin/conductin and b-catenin (Polakis, 1997) . Under physiological conditions, complex formation induces the rapid degradation of b-catenin. In colon carcinoma cells, defective b-catenin degradation leads to the accumulation of intact b-catenin in the nucleus, where it binds to and activates the Tcf-4 transcription factor. The region within the APC protein necessary for the complex formation and initiation of b-catenin degradation is located in the N-terminal and middle part of the protein (Rubinfeld et al., 1993) . The APC protein has a microtubuli binding domain clearly distinct from this region at the C-terminal end. It is well established that wild-type, but not truncated APC protein associates with microtubules in vivo and promotes their assembly in vitro (Munemitsu et al., 1994) thus aecting important microtubule processes, e.g. the establishment of cell polarity (Drubin and Nelson, 1996) , the localization and organization of cell organelles as well as intracellular vesicle tracking. In addition, APC is involved in microtubuli dependent cell migration and localization of APC is reported to be concentrated in puncta at the leading edge of prominent membrane protrusions (NaÈ thke et al., 1996) . It is still unclear by which mechanism APC protein is exaggerating this function.
The most likely candidates to be involved in this localization process are the members of the still growing and highly conserved EB/RP protein family (Juwana et al., 1999; Korinek et al., 2000) . EB1 and RP1 protein are characterized by their capability to bind to the C-terminal part of APC and to tubulin. Moreover, the fact that both proteins localize along nuclear and cytoplasmic microtubules throughout the cell cycle, as well as to the plus ends of cytoplasmic microtubules strengthen the position that members of the EB/RP protein family may be important for microtubule-based processes (Juwana et al., 1999) . A critical role for EB/RP proteins in mitosis processes is suggested by the mitotic defects observed in yeast where EB1/RP1 homologues (BIM1p, Mal3, YEB1) have been characterized (Schwartz et al., 1997; Beinhauer et al., 1997) . Mal3 deletion mutants showed condensed chromosomes, a sign for mitosis delay and in BIM1p deleted cells the spindle was found to be abnormally short. In addition, Bim1p promotes cytoplasmic microtubule dynamics speci®cally during G1. During G1, microtubules in cells lacking BIM1p showed reduced dynamicity due to a slower shrinkage rate, fewer rescues and catastrophies, and more time spent in an attenuated/paused state (Tirnauer et al., 1999) . A delay in the cell cycle before cytokinesis in cells with mutated EB1/RP1 homologues was observed in budding yeast as well (Muhua et al., 1998) . At least in yeast, homologues of the human EB/RP protein family may be a necessary component of a new cellcycle checkpoint. After sensing a misorientated or defective spindle, the EB1/RP1 checkpoint may activate a signal to delay the cell cycle.
The functions of the human EB/RP proteins are still unknown and cannot be studied entirely in yeast as a yeast homologue of the human APC protein has not been identi®ed. Based on the high degree of conservation across species, they are postulated to play a similar role in regulating the behaviour of microtubules. We had discovered the RP1 protein initially in activated T-cells and RNA expression experiments had indicated that the RP1 gene belongs to the immediate/ early gene family as its expression is up-regulated rapidly and shut down 4 ± 12 h after T-cell activation. To study in more detail the molecular mechanism for the transcriptional regulation of the human RP1 gene, we set out to localize the gene within the human genome and to characterize its promoter.
Results

Chromosomal localization of the RP1 locus
The RP1 gene locus was found to be located on chromosome 18q21 by¯uorescence in-situ-hybridization (Figure 1a,b) . In more than 20 metaphase plates, this localization could be detected on the metaphase chromosome 18 with two distinct¯uorescence signals. The software`electronical PCR' (National Institute of Health, USA) con®rmed this result. Until today, a small part of the RP1 cDNA end (2439 ± 2591) has been sequenced by the human genome project and assigned to the region q21 on chromosome 18 (dbSTS 11588-G06091, sbSTS 55305-G37745).
RP1 expression in colorectal cell lines
The RP1 mRNA level in dierent colorectal cell lines was analysed by quantitative RT ± PCR. To start, the quantity and integrity of cDNAs generated from four cell lines were analysed measuring the average expression levels for two house keeping genes (p53 and HPRT (hypoxanthine-guanine phosphoribosyltransferase)). Two cell lines (SW 620 and HT 29) lacking the entire long arm of chromosome 18 or parts of it were compared with two cell lines containing both intact RP1 alleles (Lovo and HCT 16). All cell lines do have a mutated APC allele (except for HCT 16 where the APC status is unknown for). The almost diploid SW 620 cells revealed an extremely low RP1 expression level, whereas hypertriploid HT 29 cells (also lacking one chromosome 18) contained almost the same amount of RP1 mRNA as the hyperdiploid Lovo and pseudo diploid HCT 16 cells (Figure 2 ). All PCRs were done in triplicate and average values are shown in the diagram. According to the test results, standard regression coecients for p53, HPRT and RP1 were determined by means of cDNA dilution series. The screening of a g-phage DNA library resulted in a clone with a size of 15 kbp which was further subdivided by restriction digest and subcloned into bacterial plasmids. From the colonies which hybridized with the very 5' cDNA probe of RP1, one clone with the size of 1960 bp was used for subsequent analysis and sequenced. Three transcription start sites at positions +1, +132, +144 were determined within this fragment by the primer extension assay (Figure  3a,b) . The start site at position +144 revealed the strongest signal in all assays and, therefore, may represent the major transcription start site. All three DNA fragments were eluted from the polyacrylamid gel and con®rmed to be true RP1 promoter fragments by an internal/nested PCR in order to exclude false positive results (data not shown).
RP1 promoter activity
The mammalian cells (293 and Jurkat) were used to study the activity of the RP1 promoter and its dierent fragments. To assure that these cell lines express RP1 mRNA message endogenously and, therefore, should have RP1 promoter binding elements, we ®rst analysed expression indirectly by quantitative real time RT ± PCR (Figure 4a,b) . Considering the dilution rate (RNA-, cDNA-, PCR-preparation), we found about 535 mRNA copies per 293 (PCR cycle 27,46) and 945 copies per Jurkat (PCR cycle 26,79).
In a ®rst step, pGL3-constructs containing various DNA fragments from the 5'-region of the RP1 gene were transfected into 293 cells. The endogenous activity of the native promoter was determined by the luciferase reporter gene assay (Figure 5a,b) . The DNA fragment +1/+445, which contained all three transcription start sites and extended to the codogene region of the ®rst RP1 exon was the strongest one and de®ned to be 100% active. The DNA-fragment 7965/71 extending to the ®rst transcription start site +1 showed no signi®cant promoter activity. The longest pGL3-RP1 promoter construct containing all three transcription sites (7965/ +445) was found to be 87% active. As a negative control, the pGL3 basic vector without an insert was used and proved to have a basic activity of less than 1%. The pGL3 vector driven by the SV40 promoter revealed only 11% activity. In this ®rst set of assays we could demonstrate, that the major enhancer element of the RP1-promoter is located in the DNA fragment +1/ +445 and that the RP1-promoter has a 10 times higher activity than the already strong SV40 promoter.
In order to determine the major promoter region in more detail, the endogenous RP1 transcription start sites were removed by the deletion of the ®rst 30 bp (starting from the ®rst bp of the initiation site) ( Figure  6a ,b). An arti®cial minimal promoter consisting of the human immunode®ciency virus TATA box and the adenovirus major late promoter initiator element was inserted 3' behind the genomic RP1-DNA. The viral transcriptional start site was located within the initiator element. The +174/+445 DNA-fragment was the most active construct in the pHIVTATAluc vector Figure 3 Identi®cation of potential transcription start sites within the RP1 gene. (a) The search for potential transcription start sites within the RP1-promoter region was done by primer-extension-analysis. Arrows (1, 2 and 3) indicate the three cDNAfragments isolated. The DNA sequence generated with the same anti-sense primer (+427) as used during the speci®c cDNAgeneration was run in parallel and facilitated the immediate identi®cation of start site sequences. (b) DNA sequence of the isolated transcription start site. Identi®ed transcription start sites are marked by black boxes system and de®ned to be 100%. Shorter fragments from within this DNA region of the RP1 gene (+174/ +346 and +234/+445) revealed 78% and 64% of this activity, respectively. The shortest active region was 112 bp long (+234/+346) and demonstrated a similar activity of 55%. All other DNA fragments were signi®cantly weaker (55%) and presented with close to base-line activity. As a control, the pHIVTATAluc vector containing only the minimal promoter was used. The pGL3control vector, containing the strong SV40 promoter was only 12% active (Figure 6a, b) , indicating again that the RP1 gene is regulated by a very strong promoter.
Characterization of protein/DNA interaction by electromobility shift assay
In a ®rst attempt, the entire 112 bp dsDNA fragment (bp +234/+346) was incubated with protein-extracts from nuclei isolated from resting and activated (stimulated for 0, 4, 6 and 24 h) Jurkat cells (Figure 7a, b) . Jurkat cells were used since RP1 RNA expression can be rapidly induced to high levels in this cell line after activation (Renner et al., 1997) . The protein/DNA-interaction reached maximum levels after 4 h (lane 4) and 24 h (lane 6) and dierent protein/ DNA-complexes could be detected (Figure 7b ). The relative promoter activities of the dierent genomic RP1-DNA-fragments were analysed in the pGL3-vector system. DNA-fragments covering the indicated DNA regions were cloned into the pGL3 vector. Plasmids were transfected into 293 cells, extracts prepared and luciferase activity determined as described. The DNA fragment +1/+445, which contains all three potential transcription start sites and extends to the codogene region of the ®rst RP1 exon was the strongest one and de®ned to be 100% active Figure 6 Analysis of RP1 promoter activity lacking endogenous transcription start sites. (a) Schematic overview of the dierent pHIVTATAluc-RP1 constructs. To analyse the transcriptional activity of the RP1 promoter in more detail, the endogenous transcription sites were deleted and replaced by an arti®cial start site integrated within the pHIVTATAluc vector system. (b) Dierent DNA fragments of the indicated position and lengths were analysed. The most active construct was the +174/+445 DNA-fragment and de®ned to be 100% active. The pGL3-SV40-vector was used as control and revealed a moderate activity of 12% (lanes 1, 2,  3 ), probe b (lanes 4, 5, 6) and probe c (lanes 7, 8, 9)) were incubated with reaction buer (K) alone (lanes 1, 4 and 7), nuclear extracts from resting (7) (lanes 2, 5 and 8) or activated (+) (lanes 3, 6 and 9) Jurkat cells (mixture of harvest cells after activation of 4, 6 and 24 h), respectively. (d) As control, the three synthetic oligo-nucleotides were incubated with nuclear extract from Hela cells (H) and with reaction buer only To identify the most likely transcription factor regulating the RP1 promoter, the 112 bp DNA fragment (+234 /+346) was subdivided into three fragments (probe a, b and c; as indicated in Figure 7a ). The three double stranded oligo-nucleotides were incubated with nuclear extracts obtained from resting and activated Jurkat cells (harvested after 4, 6 and 24 h) (Figure 6c ) or from Hela nuclear extract ( Figure  7d) . Probe a showed no interaction with proteins from nuclear Jurkat extracts (Figure 7c, lanes 1 ± 3) , whereas probe b reacted with nuclear Jurkat proteins from activated cells only (Figure 7c, lane 6) . Probe c interacted with nuclear proteins from resting ( Figure  7c , lane 8) as well as activated Jurkat cells (Figure 7c , lane 9). In comparison, all three probes interacted with the commercially available nuclear Hela extracts ( Figure 7d, lanes 2, 4 and 6) .
The previous results demonstrated that the main RP1 promoter activity was located within the region +234/+346 as we could observe promoter activity and protein/DNA interaction within this DNA region.
Using the software`MatInspector professional' (Genomatix Software GmbH, Quandt et al., 1995) , we identi®ed in the DNA region probe b the cyclic AMP responsive element (CRE) with the highest predictive score (Figure 8d) .
A binding assay was performed to con®rm the speci®c interaction of CREB1 and the RP1 promoter (Figure 8 ). For this purpose, we used the GST-CREB1 protein fragment aa 218 ± 326, including the native dimerization and DNA binding region (Figure 8a,b) . The GST-KCREB1 protein (aa: 218 ± 326, mutation: C 288 ?L) served as a control, because this mutated CREB variant is unable to bind to CRE. The native glutathione S-transferase (GST) protein served as an additional negative control (Figure 8a,b) . As positive controls, dsDNA probes from chromogranin b and secretogranin II (both containing classical CRE's) were used to demonstrate the speci®c interaction of RP1 probe b with CREB proteins (Figure 8c,d) . This speci®c interaction was demonstrated by clear shifts with all probes used (Figure 8c ). The control proteins KCREB1 and GST did not bind to any of these dsDNA's. A supershift assay was done to con®rm the speci®c binding of CREB2 within the RP1 promoter (data not shown). A CREB2 speci®c anti-serum demonstrated a clear supershift with nuclear extracts obtained from rested and activated Jurkat cells but not with commercially available Hela nuclear cell extracts in the presence of RP1-probe b (data not shown).
Discussion
One of the most interesting features of the members of the EB/RP protein family is their ability to bind to the C-terminal region of the APC protein as the functional inactivation of the APC protein is a key event in colorectal tumorigenesis (Bodmer et al., 1987; Groden et al., 1991) . Ninety-four per cent of all APCmutations result in the expression of a truncated protein by introducing a stopcodon within the open reading frame (Van der Luijt et al., 1994) . Patients heterozygous for this gene defect do not necessarily develop colorectal cancer but are at much greater risk to do so than the general population (Kinzler and Vogelstein, 1996) . Individuals having both a wild-type and mutant APC allele (familial adenomatous polyposis (FAP)) eventually develop hundreds to thousands of polyps in the large intestine at an early age (Kinzler and Vogelstein, 1996) .
The cellular distribution pattern of EB1/RP1 characterized by its speci®c colocalization with APC at the plus end of microtubles suggests that these proteins are functionally linked. More interesting in this context is the fact that both, APC (chromosome 5q) and RP1 are located within chromosomal regions known to be lost or altered in a high percentage of colorectal cancers, too. The localization of the RP1 gene on chromosome 18q21 links RP1 to a region that is aected in up to 50% of all patients with colorectal cancer (Ogunbiyi et al., 1998) . The 18q chromosomal region is frequently altered either by a complete loss of the long arm or by deletions in the q21-23 region. Several candidate tumour suppressor genes have been mapped to this chromosomal region so far, including DCC, DPC4 and MADR2 (Tarafa et al., 2000) . The latter two genes are members of the Smad family, key downstream mediators in the transforming growth factor beta signalling pathway, and their alterations confer resistance to transforming growth factor beta and contribute to tumorigenesis. However, recent data indicate the presence of at least two additional, as yet unidenti®ed tumour suppressor genes in this chromosomal region (Papadimitrakopoulou et al., 1998) . Loss of heterozygosity (LOH) in the long arm of chromosome 18 is suggested to be related to poor survival and possibility to the development of metastases (Jernvall et al., 1999 ). An increased rate of tumour recurrence is the reason for poor survival among patients with LOH at 18q21 in primary cancer. From a clinical point of view, chromosome 18q allelic loss is therefore a prognostic marker in colorectal cancers and clinical protocols are currently under development which will use chromosome 18 LOH as a marker to identify patients who are at high risk for recurrence. Our mRNA expression analysis by quantitative RT ± PCR con®rmed that the loss of chromosome 18q correlates with a signi®cantly reduced RP1 expression as postulated. This loss of RP1 expression was independent from the absence of an intact APC allele. Since the function of the RP1 protein might be important in the context of the initiation process of colorectal cancer, we decided to study its gene locus in more detail.
The analysis of the 5'¯anking region of the RP1 DNA revealed that a short fragment of 112 bp contains a very active promoter region. Comparative analysis showed that the RP1 promoter was 10 times more active in the cell systems used than a control SV40 promoter. By promoter sequence analysis, CREB proteins were identi®ed to be likely transcription factors. Their speci®c binding to the RP1 promoter was con®rmed by electromobility shift assays. The cDNA encoding RP1 was initially isolated from activated T-cells after eective stimulation via combined CD3 and CD28 antigen crosslinking (Renner et al., 1997) . The fact that the RP1 promoter is regulated by CREB1 and 2 provides a link back to the process of T-cell activation (Butscher et al., 1998; Hsueh et al., 1997; Feuerstein et al., 1995) . It is well established that signalling through the CD28 receptor leads to the activation of the so-called CD28 response element (CD28RE) which in turn is responsible for the induction of the interleukin-2 promoter in T-cells. Characterization of a DNA anity-puri®ed complex that binds to the CD28RE revealed the presence of the transcription factors c-Rel, ATF-1, and CREB2 (Butscher et al., 1998) . Exogenous expression of c-Rel in combination with ATF-1 or CREB2 showed synergistic transactivation of the CD28RE in quiescent T-cells. Therefore, signalling through the T-cell receptor is likely to occur through the cooperative induction of two distinct transcription factor families: the Rel family (including c-Rel, p65, p50 and RelB) and the CREB family (including CREB1, ATF-1 and CREB2) (Butscher et al., 1998) .
Up to date, no direct involvement of CREB into the formation of colorectal tumours through the APC/bcatenin pathway has been established. However, Takemaru and Moon (2000) published recently compelling evidence that b-catenin interacts directly with the CREB-binding protein CBP and synergized to stimulate the activity of a synthetic reporter in vivo. They suggested that CBP provides a link between bcatenin and the transcriptional machinery, and possibly mediates the oncogenic function of b-catenin. One of the new target genes of b-catenin identi®ed is cyclin D1 (Tetsu and McCormick, 1999) . Tetsu and McCormick (1999) could demonstrate that b-catenin activates the transcription of cyclin D1 through TCFbinding sites within the promoter. The activity of the cyclin D1 promoter was enhanced after CREB binding. This is in accordance with a report showing that the cyclin D1 promoter is a likely target for CREB proteins (Beier et al., 1999) . Therefore, b-catenin and CREB synergize in the regulation of the cyclin D1 promoter activity. Increased transcription of cyclin D1 is likely to play an important role in the development of colon cancer and other malignancies involving these pathways.
In conclusion, the chromosomal localization and the regulation of the RP1 gene promoter establishes another potential link between the EB/RP protein family and APC dependent colorectal cancer. The more detailed analysis of the regulation of the APC gene itself and its interacting proteins will hopefully provide new insight into the process of APC dependent tumorigenesis.
Materials and methods
Cell culture and nuclear extracts
The Jurkat T cell line and the 293 kidney cell line were obtained from the American Tissue Culture Collection. The four colorectal cell lines (SW620, HT29, LOVO, HCT16) were obtained from the DSMZ (Braunschweig, Germany). Cells were cultured in RPMI 1640 medium, supplemented with 10% (v/v) FCS, glutamine 2 mM/l, streptomycin (100 mg/ml) and penicillin (100 IU/ml) (all Gibco-BRL, Karlsruhe, Germany) at 378C in 5% CO 2 . Jurkat stimulation assays were done with PHA (Phytohaemagglutinin, Munich, Germany) (5 mg/ml) for 24 ± 48 h. Resting and PHA activated (0, 4, 6, 24 and 48 h) Jurkat cells were used as a source for nuclei. For this purpose, 5610
7 Jurkat cells were lysed with 500 ml lysis buer (50 mM KCl, 0.5% Nonidet P-40, 25 mM HEPES (N-2-Hydroxyethylpiperazine-N'-2-ethansulphonic acid) pH 7.8, 1 mM phenylmethylsulphonyl¯uorid (PMSF), 10 mg leupeptin/ml, 20 mg aprotinin/ml, 100 mM dithiothreitol (DTT)) on ice (4 min). After 1 min of centrifugation (15 000 g), supernatant was recovered as cytoplasmic extract. Nuclei were washed once more with the same volume of buer without Nonidet P-40, added to 300 ml extraction buer (500 mM KCl, 10% glycerol, 25 mM HEPES, pH 7.8, 1 mM PMSF, 10 mg leupeptin/ml, 20 mg aprotinin/ml, 100 mM DTT) and mixed several times. After centrifugation (14 000 g, 5 min), the supernatant was harvested as the nuclear protein extract and stored at 7708C.
Polymerase chain reaction (PCR) and synthetic oligo-nucleotides
All PCR reactions were performed as described (Renner et al., 1997) using standard PCR conditions: 958C 5 min, 948C 1 min, annealing 608C, 1 min, extension 728C 2 min for 35 cycles. PCR chemicals including high ®delity Taq were obtained from Boehringer Mannheim (Mannheim, Germany). Electrophoretically separated cDNA's were isolated from the polyacrylamide gel by standard methods (Sambrook et al., 1989) and used as template for PCR-ampli®cation (elution buer: 0.5 M NH4+-Acetat, 10 mM Mg-acetate, 1 mM EDTA (pH 8), 0.1% SDS).
Chromosomal localization of the human RP1 gene by fluorescence in-situ hybridization (FISH)
Standard human chromosome preparations were made from phytohaemagglutinin-stimulated lymphocyte cultures obtained from healthy donors. For FISH analysis, a full-length RP1 cDNA probe (1100 bp) was biotinylated using the BioNick labelling kit (Gibco ± BRL, Karlsruhe, Germany) and visualized with Cy3 (Dianova, Hamburg, Germany). After the FISH procedure,¯uorescence R-banding was performed as previously described (Zhang et al., 1998) . The ISIS and IKS3 software packages (Metasystems, Althussheim, Germany) were used for documentation of FISH and R-banding results.
Isolation of the genomic RP1 clone
To characterize the human RP1 promoter, a probe corresponding to the ®rst 250 bp of the RP1 cDNA was generated by PCR (primer: +445/+695) and used to screen a genomic placenta lgt10 library (Clontech, Heidelberg, Germany). Positive colonies were detected by Southern blotting (Sambrook et al., 1989) and subcloned after HindIII digest into pBS KS+ (Stratagene, Heidelberg, Germany). DNA sequencing was performed according to standard procedures using automated DNA sequencing ((SequiTherm EXCELII Long-Read DNA Sequencing Kit-LC, Biozym, Oldenburg, Germany) Sequencing automat LICOR 4000L (MWG, Munich, Germany)). Nucleotide sequence data were analysed using public data bases as described (Renner et al., 1997) .
Primer extension analysis
Total RNA from resting and stimulated Jurkat cells was isolated with guanidinium isothiocyanat as described (Renner et al., 1997) and the primer extension analysis performed according to standard methods (Sambrook et al., 1989) . In brief, 10 mg of total RNA was hybridized with an end labelled primer ((T4-Polynucleotidkinase, Promega, Mannheim) and gamma-32 -P-ATP) corresponding to the region 18 bp (+445) upstream of the translation start codon of the anti-sense strand of the human RP1-cDNA. The hybridization mixture was heated up to 758C for 15 min and then incubated at 428C for further 40 min. In addition, DNA sequencing reactions using this same primer (Sambrook et al., 1989) were performed. The products were generated by cDNA-extension (M-MLV RT, Promega M1701, Mannheim) and analysed together with the sequence reaction on a denatured 6% polyacrylamide gel.
Quantitation of RP1-mRNA expression by real-time PCR 1 ± 5610 5 Jurkat and 293 cells were harvested, RNA extracted (RNA mini isolation kit, Qiagen, Hilden, Germany) and resuspended in a volume of 50 ml. An aliquot of 1 ml was reverse transcribed using Omniscript-RT (Qiagen, Hilden, Germany) and an oligo-(dT 15 ) primer in a total volume of 20 ml. Then, 40 ampli®cation cycles were performed with 0.5 ml of each cDNA (20 ml reaction volume) (LightCyclerFastStart DNA Master SYBR Green I, Roche, Mannheim, Germany). RP1-speci®c cDNA primer sense (AATTCTAT-GATGCTAACTACGATGGGAAGG) and anti-sense (GGGGGAGTTTGCATGGTGAGACTTTTTTGG) were used under following PCR conditions: SYBR Green I detection, 958C 10 min, 958C 15 s, 608C 15 s and 728C 25 s. b-actin gene ampli®cation (sense CTACAATGAG-CTGCGTGTGGC, anti-sense GCGGATGTCCACGTCA-CACTTC) was done to assure the quality of the isolated mRNA. For quanti®cation, a regression linear was generated using pBI-eGFP vector (Clontech, Heidelberg, Germany) incorporating the codogene region of the RP1 gene To measure RP1 mRNA expression in dierent colorectal tumour cell lines, cDNA from the almost diploid SW 620, the hypertriploid HT 29 (both lacking one chromosome 18), the hyperdiploid Lovo and pseudo diploid HCT16 (both containing intact RP1 alleles) was extracted as described above. The quantitative RP1 PCR was performed under the same conditions as described above. House keeping genes (HPRT (Xq26) and p53 (17p)) were selected on the basis that they are not encoded on chromosome 18. Ampli®cation for p53 and HPRT was done as described using the following primer sets: p53 (5'-CGTGAGCGCTTCGAGATGTTCCG, 3'-CCTAA-CCAGCTGCCCAACTGTAG) and HPRT (5'-CCATCA-CATTGTAGCCCTCTGTGTGC, 3'-AGCTTGCGACCTT-GACCATCTTTGG).
Reporter plasmids, luciferase assay
The promoter activity was assayed by the Dual-luciferase Reporter Assay System (Promega, Mannheim, Germany). The pRL vector that is designed to provide constitutive expression of Renilla luciferase in mammalian cells was used as an internal standard. Various length fragments that are part of the RP1 5'-¯anking region were inserted upstream of the luciferase gene in the pGL3-Basic vector (Promega, Mannheim, Germany), which lacks eukaryotic promoter and enhancer sequences. In a second set of experiments, RP1-fragments were inserted into the pHIVTATAluc vector. In this vector system, the transcription unit synthesis of luciferase mRNA is under the control of a minimal promoter consisting of the human immunode®ciency virus TATA box and the adenovirus major late promoter initiator element . As a positive control, pGL3 control vector which contains the simian virus 40 (SV 40) early promoter upstream of the luciferase gene was used. The following RP1-fragments were inserted into the pGL3-basic vector (Promega, Mannheim) through speci®c restriction sites (MluI/EcoRI): 7965/71, 7965/+445, +1/+445. The PCR products lacking the ®rst 40 ± 50 bp of the native transcription initiation-start site +51/+132, +174/+445, +174/ +346, +174/+234, +234/+445, +234/+346, +346/+445 were inserted into the pHIVTATAluc vector. Promoter activity was analysed in mammalian 293 cells. For this purpose, cells were plated out (5610 4 cells per well) in a 24-well plate and cultured overnight before transfection. The pRL vector as well as the pGL3 and pHIVTATluc vectors with or without inserts were co-transfected (FUGENE 6, Roche, Mannheim, Germany). Cells were harvested 48 h after transfection and cell lysates prepared. Light output was integrated over a 10 s period after a 1 s pre-read delay using a Lumicounter LB 9501 (Berthold, Germany). The expression of the ®re¯y luciferase reporter gene was normalized by the value of the expression of the Renilla luciferase gene. Every experiment was done at least in triplicate.
Expression of recombinant CREB1 and KCREB fusion proteins in E. coli To express the DNA binding and dimerization domains of KCREB1 (aa: 218 ± 326, mutation: C 288
